Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone | Patent Publication Number 20230277660

US 20230277660 A1
Patent Number-
Application Number18300183
Filled DateApr 13, 2023
Priority DateMar 28, 2019
Publication DateSep 7, 2023
Original Assignee
Current AssigneeJanssen Research & Development
Inventor/ApplicantsMing Qi
Christoph Heuck
Zhilong Yuan
Pamela Clemens
Rajesh Bandekar
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.